@asparagoid For those curious about science which supports this hypothesis: Arillotta, D.,

Partially SupportedGLP-1 receptor agonists act in reward/pleasure pathways involved in addiction, sexual desire, and potentially love.

Partially SupportedThe GLP-1R agonist semaglutide reduces motivated running and alters dopamine dynamics in the nucleus accumbens.

Partially SupportedThe GLP-1 analogue Exendin-4 attenuates nicotine-induced locomotor stimulation, accumbal dopamine release, and associated behavioral changes in mice.

Partially SupportedCentral GLP-1 signaling has implications for food and drug reward.

Partially Supported